A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma

Purpose This prospective study aims to explore the benefit of cytokine-induced killer cell (CIK) treatment in hepatocellular carcinoma patients, which has not yet been thoroughly studied before.